Arsanis, Inc.

/Arsanis, Inc.

They are a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases.


Price Range
$15.00 - $17.00

Anticipated Shares

Effective Date
November 16, 2017


To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange